Inconsistency of Synergy Between the β-Lactamase Inhibitor CP-45,899 and β-Lactam Antibiotics Against Multiply Drug-Resistant Enterobacteriaceae and Pseudomonas Species

Synergy between CP-45,899 and ampicillin or newer β-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and Pseudomonas species was inconsistent. In contrast, synergy between CP-45,899 and ampicillin against β-lactamase-producing strains of Haemophilus influenzae type b and Bactero...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Autor principal:	Fass, Robert J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1981
Assuntos:	Physiological Effects and Microbial Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181432/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6289732/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.2.361
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!